APA (7th ed.) Citation

A, S., E, B., RC, R., M, A., SS, W., K, B., . . . W, S. (2022). Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer's disease brain extracts. Alzheimer's research & therapy, 14(1), 196. https://doi.org/10.1186/s13195-022-01141-1

Chicago Style (17th ed.) Citation

A, Sandberg, Berenjeno-Correa E, Rodriguez RC, Axenhus M, Weiss SS, Batenburg K, Hoozemans JJM, Tjernberg LO, and Scheper W. "Aβ42 Oligomer-specific Antibody ALZ-201 Reduces the Neurotoxicity of Alzheimer's Disease Brain Extracts." Alzheimer's Research & Therapy 14, no. 1 (2022): 196. https://doi.org/10.1186/s13195-022-01141-1.

MLA (9th ed.) Citation

A, Sandberg, et al. "Aβ42 Oligomer-specific Antibody ALZ-201 Reduces the Neurotoxicity of Alzheimer's Disease Brain Extracts." Alzheimer's Research & Therapy, vol. 14, no. 1, 2022, p. 196, https://doi.org/10.1186/s13195-022-01141-1.